These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1901836)

  • 21. Inhibition in rat of development of in utero galactose-induced cataract by an aldose reductase inhibitor--a light microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1991; 35(3):317-24. PubMed ID: 1770672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
    Kador PF; Betts D; Wyman M; Blessing K; Randazzo J
    Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose reductase catalyzes the oxidation of naphthalene-1, 2-dihydrodiol for the formation of ortho-naphthoquinone.
    Sugiyama K; Wang TC; Simpson JT; Rodriguez L; Kador PF; Sato S
    Drug Metab Dispos; 1999 Jan; 27(1):60-7. PubMed ID: 9884310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldose reductase and its inhibition in the control of diabetic complications.
    Narayanan S
    Ann Clin Lab Sci; 1993; 23(2):148-58. PubMed ID: 8457142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
    Kim J; Kim CS; Sohn E; Lee YM; Kim JS
    J Pharm Pharmacol; 2011 Oct; 63(10):1301-8. PubMed ID: 21899546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
    Takemoto DJ; Harris R; Brightman A; McGill J; Hua D; Davidson H; Fenwick B; Wagner LM
    Vet Ophthalmol; 2004; 7(3):163-7. PubMed ID: 15091323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
    Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
    Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts.
    Kador PF; Randazzo J; Babb T; Koushik K; Takamura Y; Zhu W; Blessing K; Kompella UB
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Diabecon on sugar-induced lens opacity in organ culture: mechanism of action.
    Moghaddam MS; Kumar PA; Reddy GB; Ghole VS
    J Ethnopharmacol; 2005 Feb; 97(2):397-403. PubMed ID: 15707781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of curcumin on galactose-induced cataractogenesis in rats.
    Suryanarayana P; Krishnaswamy K; Reddy GB
    Mol Vis; 2003 Jun; 9():223-30. PubMed ID: 12802258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The distribution of aldose reductase and aldehyde reductase II in different regions of bovine lens.
    Liu S; Das B; Srivastava SK
    Lens Eye Toxic Res; 1989; 6(3):415-30. PubMed ID: 2518623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
    Unakar NJ; Tsui JY; Johnson MJ
    Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The inhibitory effect of aldose reductase inhibitor for proliferation in the lens epithelial cells of rat sugar cataract].
    Morikubo S; Takamura Y; Kubo E; Tsuzuki S; Akagi Y
    Nippon Ganka Gakkai Zasshi; 2003 Oct; 107(10):565-70. PubMed ID: 14598706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of lens epithelium in cataract formation in diabetic rats].
    Fan W; Yan M; Hu Y; Li G
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):185-8. PubMed ID: 10684012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
    Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract.
    Suryanarayana P; Kumar PA; Saraswat M; Petrash JM; Reddy GB
    Mol Vis; 2004 Mar; 10():148-54. PubMed ID: 15031705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.